Characterization of growth factor-induced serine phosphorylation of tumor necrosis factor-alpha converting enzyme and of an alternatively translated polypeptide.
about
Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumabMammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulinA Disintegrin and Metalloprotease 17 in the Cardiovascular and Central Nervous SystemsThe transmembrane domain of TACE regulates protein ectodomain sheddingCharacterization of angiotensin-converting enzyme 2 ectodomain shedding from mouse proximal tubular cellsIdentification of novel interaction between ADAM17 (a disintegrin and metalloprotease 17) and thioredoxin-1.Sensitization of cerebral tissue in nude mice with photodynamic therapy induces ADAM17/TACE and promotes glioma cell invasion.ADAM-17: the enzyme that does it all.TACE/ADAM-17 phosphorylation by PKC-epsilon mediates premalignant changes in tobacco smoke-exposed lung cellsmiR-221/222 control luminal breast cancer tumor progression by regulating different targets.TIMP3: a physiological regulator of adult myogenesis.Interleukin-1 stimulates ADAM17 through a mechanism independent of its cytoplasmic domain or phosphorylation at threonine 735A disintegrin and metalloenzyme (ADAM) 17 activation is regulated by α5β1 integrin in kidney mesangial cells.Regulation of myogenic activation of p38 MAPK by TACE-mediated TNFα releaseA1 adenosine receptor-stimulated exocytosis in bladder umbrella cells requires phosphorylation of ADAM17 Ser-811 and EGF receptor transactivation.Metalloprotease inhibitors GM6001 and TAPI-0 inhibit the obligate intracellular human pathogen Chlamydia trachomatis by targeting peptide deformylase of the bacterium.Membrane-enabled dimerization of the intrinsically disordered cytoplasmic domain of ADAM10.Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation.Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation.TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association.The ADAM17-amphiregulin-EGFR axis in mammary development and cancer.TACE release of TNF-alpha mediates mechanotransduction-induced activation of p38 MAPK and myogenesis.Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.Inhibitory role of TACE/ADAM17 cytotail in protein ectodomain sheddingA role for cGMP in inducible nitric-oxide synthase (iNOS)-induced tumor necrosis factor (TNF) α-converting enzyme (TACE/ADAM17) activation, translocation, and TNF receptor 1 (TNFR1) shedding in hepatocytes.Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization.ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding.TIMP3 Modulates GHR Abundance and GH SensitivityMetalloproteases and gamma-secretase: new membrane partners regulating p75 neurotrophin receptor signaling?Src mediates the mechanical activation of myogenesis by activating TNFα-converting enzymePhosphorylation of the JAK2-STAT5 pathway in response to acute aerobic exercise.ATP-mediated activation of the NADPH oxidase DUOX1 mediates airway epithelial responses to bacterial stimuli.The role of protease activity in ErbB biology.TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling.Mitochondrial reactive oxygen species mediate GPCR-induced TACE/ADAM17-dependent transforming growth factor-alpha shedding.Membrane proteases and tetraspanins.Functional interplay between tetraspanins and proteases.Pore-forming bacterial toxins and antimicrobial peptides as modulators of ADAM function.New insights into ADAMs regulation of the GRO-α/CXCR2 system: focus on Sjögren's syndrome.Staphylococcus aureus protein A activates TACE through EGFR-dependent signaling.
P2860
Q24313194-C8642837-DC21-4C56-A46F-4E7E25B55903Q24646364-F52AA464-FA6F-46DD-8357-AC76D074CF60Q28072451-1DD2EAEE-05AC-41F5-AC70-94308070E0BBQ28258815-29F7983C-B981-4D58-8ED7-81DDEF3FC8D0Q28538745-39F3FB22-0E0B-4887-A2DC-9EDE29F36336Q30415770-1F8E1BF4-BB4F-409F-8809-31AE77C09A6EQ33325051-E9E3D8E3-7F51-4566-AA8E-526D296D6920Q33737421-1F148912-8C56-4A12-B16A-827AD009B3A9Q33851440-267894D7-8BDF-47D1-A9C5-E932B5A503B3Q33952998-70BD4590-C654-439B-A335-AC4E386D4981Q34072911-B3472428-66CD-4847-9939-62D7D274635FQ34181792-74C0973C-501F-4E4D-B002-447569A61EBDQ34193829-B27347AD-6C31-4EBB-8495-28C70A700ABBQ34391396-A4C9333A-7D90-4DA5-91D9-29B4A24A9C52Q34505020-B1753CD5-C83A-4DDD-8327-A746530888AFQ34505586-70760D36-BC91-4661-A34B-F9606835C59BQ34526248-C8501FD1-1241-407C-9E95-417D36B6EF2EQ34555877-04050E5F-2AD9-4BB9-91A5-973F5D7DAC6AQ34598322-FC15D2AF-F1BF-441A-99D2-15FA3454018EQ34626693-1C196F79-1FF6-40D2-A858-0810B70DBDABQ34777834-4B4D07A9-075E-469C-8218-377FA960AB19Q34997564-E1FDABD1-CFBC-48F4-8BAC-9B322A71F20AQ35545249-9B65E8D1-F21C-453F-B0CE-CE2BDE5BA0CCQ35575197-3EC73325-3D39-4C4A-AADB-49B806A92D0AQ36332760-DDF0666D-80F0-472C-AA62-10CDB32934EEQ36715904-1ACF9F8D-BE62-41F5-B6E1-8DEE46FD7C45Q36850617-E9DD92EC-ECF3-4295-8CD6-269D8663C3C0Q36945222-50FC52C3-DDCD-4279-9760-7B4EFCC722B7Q36994561-B26D89ED-D327-4E8C-AC66-BC716B2DA958Q37201493-48A8872C-F1BB-4773-81A8-3DA2D59BE809Q37224758-7B309E0D-4626-4B4F-849E-6BC9ABE17A8CQ37285322-1D0FD0BC-7D60-485D-93D3-2107FF85CE10Q37326973-BA84BEAB-8D7C-493F-BA44-CC4281205A67Q37340230-ACEC612A-7910-4454-8B16-F606E861F1E4Q37475351-98992B0B-2B96-497E-BE82-6DB964B70DA0Q37856396-58FD0633-C113-4DC4-97F4-FA808F712339Q37891849-893A565E-DCE4-4FD6-B061-B8749EA27600Q38042836-1CC30E86-B207-44FF-A0A1-A74FD9B0872BQ38267059-F1353EEB-F4E4-4287-8339-393AFA41EA9FQ38305374-2B8F1A91-356C-4EB9-AACE-9FB463D29CED
P2860
Characterization of growth factor-induced serine phosphorylation of tumor necrosis factor-alpha converting enzyme and of an alternatively translated polypeptide.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Characterization of growth fac ...... tively translated polypeptide.
@en
type
label
Characterization of growth fac ...... tively translated polypeptide.
@en
prefLabel
Characterization of growth fac ...... tively translated polypeptide.
@en
P2093
P2860
P356
P1476
Characterization of growth fac ...... tively translated polypeptide.
@en
P2093
Christoph W Turck
Huizhou Fan
Rik Derynck
P2860
P304
18617-18627
P356
10.1074/JBC.M300331200
P407
P577
2003-03-05T00:00:00Z